THOMAS G. WIGGANS

Insider Reports History

Location
Palo Alto, CA
Signature
/s/ Herb Cross, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by THOMAS G. WIGGANS:

Company Role Class Num Shares Value Price $ Report Date Ownership
Jasper Therapeutics, Inc. Director Voting Common Stock 41,000 $99,630 $2.43 22 Sep 2025 By Wiggans Living Trust
Jasper Therapeutics, Inc. Director Voting Common Stock 5,000 $14,200 $2.84 22 Sep 2025 Direct
Annexon, Inc. Director Stock Option (Right to Buy) 55,000 05 Jun 2025 Direct
Jasper Therapeutics, Inc. Director Common Stock Warrant (right to buy) 41,000 22 Sep 2025 By Wiggans Living Trust
Jasper Therapeutics, Inc. Director Stock Option (right to buy) 7,500 03 Jul 2025 Direct
CymaBay Therapeutics, Inc. Director Employee Stock Option (right to buy) 0 22 Mar 2024 Direct
Forma Therapeutics Holdings, Inc. Director Common Stock 0 $5.05 14 Oct 2022 Direct
Forma Therapeutics Holdings, Inc. Director Stock Option (Right to Buy) 0 14 Oct 2022 Direct
PARDES BIOSCIENCES, INC. Chief Executive Officer, Director Common Stock 0 $1.50 31 Aug 2023 Direct
PARDES BIOSCIENCES, INC. Chief Executive Officer, Director Stock Option (Right to Buy) 0 31 Aug 2023 Direct

Insider Reports Filed by THOMAS G. WIGGANS

Symbol Company Period Transactions Value $ Form Type Role Filing Time
JSPR Jasper Therapeutics, Inc. 22 Sep 2025 2 +$99,630 4 Director 24 Sep 2025, 16:01
JSPR Jasper Therapeutics, Inc. 03 Jul 2025 1 $0 4 Director 03 Jul 2025, 16:21
ANNX Annexon, Inc. 05 Jun 2025 1 $0 4 Director 09 Jun 2025, 16:30
JSPR Jasper Therapeutics, Inc. 06 Jun 2024 1 $0 4 Director 10 Jun 2024, 18:20
ANNX Annexon, Inc. 05 Jun 2024 1 $0 4 Director 07 Jun 2024, 21:45
/report/000095017024035446-wiggans-thomas-g-2024-03-22 CymaBay Therapeutics, Inc. 22 Mar 2024 4 $0 4 Director 22 Mar 2024, 16:54
/report/000106299324001420-wiggans-thomas-g-2024-01-24 CymaBay Therapeutics, Inc. 24 Jan 2024 1 $0 4 Director 26 Jan 2024, 18:18
JSPR Jasper Therapeutics, Inc. 28 Nov 2023 1 +$6,486 4 Director 30 Nov 2023, 16:05
JSPR Jasper Therapeutics, Inc. 21 Nov 2023 1 +$6,383 4 Director 22 Nov 2023, 16:06
JSPR Jasper Therapeutics, Inc. 16 Nov 2023 3 +$18,240 4 Director 20 Nov 2023, 20:14
JSPR Jasper Therapeutics, Inc. 01 Nov 2023 1 $0 4 Director 02 Nov 2023, 18:00
JSPR Jasper Therapeutics, Inc. 01 Nov 2023 0 $0 3 Director 02 Nov 2023, 17:58
/report/000120919123047836-wiggans-thomas-g-2023-08-31 PARDES BIOSCIENCES, INC. 31 Aug 2023 4 $0 4 Chief Executive Officer, Director 31 Aug 2023, 14:55
ANNX Annexon, Inc. 08 Jun 2023 1 $0 4 Director 12 Jun 2023, 16:50
/report/000120919123006896-wiggans-thomas-g-2023-02-01 PARDES BIOSCIENCES, INC. 01 Feb 2023 1 $0 4 Chief Executive Officer, Director 03 Feb 2023, 15:36
/report/000106299323001498-wiggans-thomas-g-2023-01-25 CymaBay Therapeutics, Inc. 25 Jan 2023 1 $0 4 Director 27 Jan 2023, 15:34
/report/000120919122060154-wiggans-thomas-g-2022-12-05 PARDES BIOSCIENCES, INC. 05 Dec 2022 1 +$13,625 4 Chief Executive Officer, Director 07 Dec 2022, 15:29
/report/000120919122059677-wiggans-thomas-g-2022-12-01 PARDES BIOSCIENCES, INC. 01 Dec 2022 2 +$39,375 4 Chief Executive Officer, Director 05 Dec 2022, 15:21
/report/000089924322033650-wiggans-thomas-g-2022-10-14 Forma Therapeutics Holdings, Inc. 14 Oct 2022 4 $0 4 Director 14 Oct 2022, 16:06
/report/000120919122050318-wiggans-thomas-g-2022-09-14 PARDES BIOSCIENCES, INC. 14 Sep 2022 1 $0 4 Chief Executive Officer, Director 16 Sep 2022, 16:17
ANNX Annexon, Inc. 09 Jun 2022 1 $0 4 Director 13 Jun 2022, 16:44
/report/000089924322021666-wiggans-thomas-g-2022-06-08 Forma Therapeutics Holdings, Inc. 08 Jun 2022 2 $0 4 Director 09 Jun 2022, 17:34
/report/000089924322009403-wiggans-thomas-g-2022-03-02 PARDES BIOSCIENCES, INC. 02 Mar 2022 1 $0 4 Chief Executive Officer, Director 04 Mar 2022, 15:40
/report/000089924322009399-wiggans-thomas-g-2022-03-01 PARDES BIOSCIENCES, INC. 01 Mar 2022 0 $0 3 Chief Executive Officer, Director 04 Mar 2022, 15:30
/report/000106299322001696-wiggans-thomas-g-2022-01-25 CymaBay Therapeutics, Inc. 25 Jan 2022 1 $0 4 Director 27 Jan 2022, 15:54
/report/000089924321025095-wiggans-thomas-g-2021-06-17 Forma Therapeutics Holdings, Inc. 17 Jun 2021 2 $0 4 Director 21 Jun 2021, 19:05
ANNX Annexon, Inc. 02 Jun 2021 1 $0 4 Director 04 Jun 2021, 17:12